Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
Kennedy, N. A., Kalla, R., Warner, B., Gambles, C. J., Musy, R., Reynolds, S., Dattani, R., Nayee, H., Felwick, R., Harris, R., Marriott, S., Senanayake, S. M., Lamb, C. A., Al‐Hilou, H., Gaya, D. R., Irving, P. M., Mansfield, J., Parkes, M., Ahmad, T., Cummings, J. R. F., Arnott, I. D., Satsangi, J., Lobo, A. J., Smith, M., Lindsay, J. O., Lees, C. W.
Published in Alimentary pharmacology & therapeutics (01.12.2014)
Published in Alimentary pharmacology & therapeutics (01.12.2014)
Get full text
Journal Article
OC-166 Predictive factors of disease relapse following thiopurine withdrawal for sustained clinical remission of IBD
Kennedy, N A, Gambles, C J, Musy, R M, Jones, G R, Arnott, I D, Satsangi, J, Lees, C W
Published in Gut (01.07.2012)
Published in Gut (01.07.2012)
Get full text
Journal Article
OC-166Predictive factors of disease relapse following thiopurine withdrawal for sustained clinical remission of IBD
Kennedy, N A, Gambles, C J, Musy, R M, Jones, G R, Arnott, I D, Satsangi, J, Lees, C W
Published in Gut (01.07.2012)
Published in Gut (01.07.2012)
Get full text
Journal Article